S&CO Inc. Acquires 100 Shares of Mettler-Toledo International, Inc. $MTD

S&CO Inc. boosted its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 20.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 600 shares of the medical instruments supplier’s stock after purchasing an additional 100 shares during the quarter. S&CO Inc.’s holdings in Mettler-Toledo International were worth $704,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MTD. Bank of New York Mellon Corp lifted its holdings in shares of Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after buying an additional 376,419 shares during the last quarter. Alliancebernstein L.P. increased its position in Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after acquiring an additional 126,147 shares during the period. PineStone Asset Management Inc. raised its stake in Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after purchasing an additional 98,737 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Mettler-Toledo International by 42.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock valued at $361,030,000 after purchasing an additional 90,395 shares during the period. Finally, Nuveen LLC bought a new stake in Mettler-Toledo International in the 1st quarter valued at $71,897,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Activity

In other news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. The trade was a 5.56% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares in the company, valued at $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 1,527 shares of company stock valued at $1,994,981. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Stock Down 0.1%

Mettler-Toledo International stock opened at $1,438.69 on Monday. The stock has a 50-day simple moving average of $1,320.50 and a 200 day simple moving average of $1,238.16. The stock has a market capitalization of $29.64 billion, a price-to-earnings ratio of 36.43, a P/E/G ratio of 4.19 and a beta of 1.41. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,454.68.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on MTD shares. JPMorgan Chase & Co. upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Citigroup upped their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Barclays boosted their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research report on Thursday, October 2nd. Finally, Bank of America raised their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,336.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.